Page last updated: 2024-09-03

pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate and 2019 Novel Coronavirus Disease

pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate has been researched along with 2019 Novel Coronavirus Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Aite, L; Bagolan, P; Bevilacqua, F; Bucci, S; Dotta, A; Grimaldi, T; Raho, L1

Other Studies

1 other study(ies) available for pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate and 2019 Novel Coronavirus Disease

ArticleYear
The NICU during COVID-19 Pandemic: Impact on Maternal Pediatric Medical Traumatic Stress (PMTS).
    American journal of perinatology, 2022, Volume: 39, Issue:13

    Topics: Case-Control Studies; Child; COVID-19; Estrenes; Female; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Mothers; Pandemics; Pyridinium Compounds

2022